Clinical Efficacy, Survival, and Adverse Reaction Evaluation of Immune Checkpoint Inhibitor in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis

OBJECTIVE: To systematically assess the clinical effect and survival time of immune checkpoint inhibitor (ICIs) in advanced gastric cancer (GC) and adverse reactions to provide evidence-based medicine for its enhancement and adoption. METHODS: PubMed, EMBASE, ScienceDirect, Cochrane Library, China K...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ping, Zhang, Xiaomeng, Zhu, Na, Zhuang, Feifei, Zhou, Dongmei, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427293/
https://www.ncbi.nlm.nih.gov/pubmed/36050997
http://dx.doi.org/10.1155/2022/6998090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427293/
https://www.ncbi.nlm.nih.gov/pubmed/36050997
http://dx.doi.org/10.1155/2022/6998090

Ejemplares similares